Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate Ameri…

Activist investor Starboard Value is looking to shake up pharma giant Pfizer's sagging stock price.

GM's recent success puts pressure on Tesla as it fights to maintain its EV dominance ahead of today…

"We see more opportunities within equities for investors searching for yield," Bank of America's Sa…

Moderna lowered its annual sales forecast as sales of its COVID-19 vaccine dropped by 37%, fueled b…

JPMorgan said it expects Structure Therapeutics' oral GLP-1 weight loss drug candidate to generate …

US stock futures slid on Wednesday as Amazon's evidence of strong AI demand was tempered by signs o…

Nividia is still a retail darling, but last week saw individual investors pivot to names like Eli L…

India’s benchmark indices Sensex and Nifty50 were flat in morning trade on Tuesday amidst positive …

Pfizer is in early talks to acquire cancer drugmaker Seagen in a potentially multibillion-dollar de…

A September rate cut would come shortly before another major economic event: the US presidential el…

The agreement is an early sign that, despite the threat of close antitrust examinations and higher …

The number of job openings in June dropped by more than expected, according to data from the Labor …

Later on Tuesday, the Labor Department will release job openings data, and ISM will publish its man…

Arena's stock surge comes after the price this year had dropped by 35%.

The drugmaker expects 2022 revenue of $98 billion to $102 billion, which fell below analyst expecta…

In today's big story, we're looking at pharma companies' surging stocks and threatening tech darlin…

"The monthly net inflows into US equities are now averaging $1.4 billion per day, close to the all-…

The vaccine will be marketed under the brand name Comirnaty, and the FDA hopes the approval will nu…

Viking's GLP-1 drug candidate showed faster weight loss compared to drugs that are already on the m…